A Collaboration Opportunity for U.S. and Brazilian Scientists

Funding News Edition: January 09, 2019
See more articles in this edition

Research and collaboration come together in the new funding opportunity announcement (FOA) U.S.-Brazil Collaborative Biomedical Research Program (R01, Clinical Trial Optional).

The FOA provides scientists in the U.S. and Brazil a chance to pursue partnerships that address public health topics of mutual benefit to both nations, such as allergy, immunology, and infectious diseases, neurological disorders and stroke, and environmental health sciences.

Research areas of interest specific to NIAID include the following:

HIV/AIDS and Co-Morbidities—Reducing incidence of HIV, developing next-generation HIV therapies, conducting research toward HIV cure, addressing HIV-associated comorbidities, co-infections, and complications

Other Infectious Diseases—Arboviruses and emerging/re-emerging viral pathogens, bacterial infections, parasitic infections, vector biology and control, detection and surveillance of infectious diseases

Allergy, Immunology, and Transplantation—Basic human immunology, host immune response and/or regulation of the inflammatory response to microbial and/or viral infection as well as topics of interest relevant to immunity to infection and/or vaccination

Application, Budget, and Other Key Details

If you’re interested in applying, take note of these important informational items. For complete details, read the FOA, linked above, and Questions and Answers for RFA-AI-18-054, U.S.-Brazil Collaborative Biomedical Research Program (R01, Clinical Trial Optional).

  • The application—U.S. and Brazilian scientists should jointly prepare and submit a single application to NIH, where the application will undergo peer review.
  • The budget—though the proposed budget request should reflect the needs of your project, keep in mind that the budget is limited to $175,000 in direct costs for each year. The U.S. portion is not to exceed $100,000 annually and the Brazilian portion is not to exceed $75,000 annually.
  • The project period—the scope of the project should determine the project period; however, the maximum that may be requested is four years.
  • The anticipated number of awards—institutes and centers participating in the FOA intend to fund 8 to 10 awards in fiscal year 2020 and commit up to approximately $2.75 million.
  • The application deadline—March 8, 2019. Optional letter of intent is due February 8, 2019.

Direct your questions to the appropriate NIAID contact:

Contact Us

Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.

Content last reviewed on